Specifically, SKP2 is overexpressed in diffuse large B-cell lymphoma (DLBCL) and cutaneous T-cell lymphomas (CTCLs) where it is associated with poor overall survival [43] and abnormal cell growth, respectively [44]. The gene discussed is SKP2; the disease is diffuse large B-cell lymphoma.